Series B - Cyrus Biotechnology

Series B - Cyrus Biotechnology

Investment Firm

Overview

Cyrus Biotechnology is a developer of Rosetta software platform that solves drug discovery problems.

Announced Date

Dec 06, 2021

Funding Type

Series B

Highlights

Location

United States, North America

Social

Investor Lead

N/A

Participant Investors

7

Investor Name
Participant InvestorSelecta Biosciences
Participant InvestorWashington Research Foundation
Participant InvestorOrbiMed
Participant InvestoriSelect Fund
Participant InvestorTrinity Ventures

Round Details and Background

Cyrus Biotechnology raised $18000000 on 2021-12-06 in Series B

Cyrus Biotechnology is a developer of Rosetta software platform that solves drug discovery problems.

Company Funding History

10

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Feb 26, 2024
Series B - Cyrus Biotechnology
1-undefined
Jul 27, 2017
Series A - Cyrus Biotechnology
4-8.0M
Apr 06, 2016
Debt Financing - Cyrus Biotechnology
-535.0K
May 06, 2015
Seed Round - Cyrus Biotechnology
2-850.0K

Recent Activity

There is no recent news or activity for this profile.